High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis

Rheumatology (United Kingdom)

Volumn 54, Issue 4, 2014, Pages 601-608

  Daïen, Claire Immediato ^a,b   Gailhac, Sarah ^b   Audo, Rachel ^b   Mura, Thibault ^c   Hahne, Michael ^b,d   Combe, Bernard ^a,c   Morel, Jacques ^a,b  

^a LAPEYRONIE HOSPITAL   (France)

^b CNRS   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Anti TNF drug; B cells; Granzyme; Interleukin 6 inhibitor; Natural killer cells; Perforin; Regulatory T cells; Tocilizumab

Indexed keywords

ADALIMUMAB; CERTOLIZUMAB PEGOL; ETANERCEPT; GRANZYME B; PERFORIN; PERFORIN A; TOCILIZUMAB; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NATURAL KILLER T CELL; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84926471653     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu363     Document Type: Article

References (29)

1. Kishimoto T. The biology of interleukin-6. Blood 1989;74: 1-10.
2. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
3. Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M. Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 1989;83:585-92.
4. Smolen JS, Schoels MM, Nishimoto N et al. Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. Ann Rheum Dis 2013;72:482-92.
5. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235-8.
6. Roll P, Muhammad K, Schumann M et al. In vivo effects of the anti-interleukin-6 receptor inhibitor tocilizumab on the B cell compartment. Arthritis Rheum 2011;63:1255-64.
7. Yu CR, Young HA, Ortaldo JR. Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells. J Leukoc Biol 1998;64:245-58.
8. Tormo AJ, Letellier M-C, Sharma M et al. IL-6 activates STAT5 in T cells. Cytokine 2012;60:575-82.
9. Poli A, Michel T, Thérésine M et al. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 2009;126:458-65.
10. Trivedi PP, Roberts PC, Wolf NA, Swanborg RH. NK cells inhibit T cell proliferation via p21-mediated cell cycle arrest. J Immunol 2005;174:4590-7.
11. Matsumoto Y, Kohyama K, Aikawa Y et al. Role of natural killer cells and TCR gamma delta T cells in acute autoimmune encephalomyelitis. Eur J Immunol 1998;28:1681-8.
12. Fort MM, Leach MW, Rennick DM. A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis. J Immunol 1950 1998;161:3256-61.
13. Dalbeth N, Callan MFC. A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis Rheum 2002;46:1763-72.
14. Majorczyk E, Pawlik A, L-uszczek W et al. Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis. Genes Immun 2007;8: 678-83.
15. van der Linden MPM, Knevel R, Huizinga TWJ, van der Helm-van Mil AHM. Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria. Arthritis Rheum 2011;63:37-42.
16. Jiao Z, Wang W, Jia R et al. Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol 2007;36:428-33.
17. Kawashiri S-Y, Kawakami A, Okada A et al. CD4+CD25 (high)CD127(low/-) Treg cell frequency from peripheral blood correlates with disease activity in patients with rheumatoid arthritis. J Rheumatol 2011;38:2517-2521.
18. Lin S-C, Chen K-H, Lin C-H et al. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 2007;37:987-996.
19. Van Roon JAG, Hartgring SAY, van der Wurff-Jacobs KMG, Bijlsma JWJ, Lafeber FPJG. Numbers of CD25+Foxp3+ T cells that lack the IL-7 receptor are increased intraarticularly and have impaired suppressive function in RA patients. Rheumatology 2010;49:2084-9.
20. O'Sullivan BJ, Thomas HE, Pai S et al. IL-1 beta breaks tolerance through expansion of CD25+ effector T cell. J Immunol 1950. 2006;176:7278-87.
21. van Amelsfort JMR, van Roon JAG, Noordegraaf M et al. Proinflammatorymediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 2007;56:732-42.
22. Evans HG, Suddason T, Jackson I, Taams LS, Lord GM. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptoractivated monocytes. Proc Natl Acad Sci USA 2007;104: 17034-9.
23. Hartigan-O'Connor DJ, Poon C, Sinclair E, McCune JM. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods 2007;319:41-52.
24. Yamada H, Nakashima Y, Okazaki K et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis 2008;67: 1299-304.
25. Wang W, Shao S, Jiao Z et al. The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol Int. 2012;32: 887-93.
26. Aramaki T, Ida H, Izumi Y et al. A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis. Mod Rheumatol 2009;19: 245-52.
27. Park Y-W, Kee S-J, Cho Y-N et al. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum 2009;60:1753-63.
28. Aggarwal A, Sharma A, Bhatnagar A. Bi(o)communications among peripheral blood fractions: a focus on NK and NKT cell biology in rheumatoid arthritis. Autoimmunity 2013;46: 238-50.
29. Anolik JH, Ravikumar R, Barnard J et al. Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks. J Immunol 2008;180:688-92.